Characterisation of a novel group B oncolytic adenovirus, ColoAd1

<p>Developing high potent oncolytic virus with multimodal antitumour capabilities is crucial for realizing the full potential of oncolytic virotherapy in cancer treatment. ColoAd1 is a novel replicating chimeric group B adenovirus recently bioselected from a large library of recombinant virus...

Повний опис

Бібліографічні деталі
Автор: Di, Y
Інші автори: Seymour, L
Формат: Дисертація
Мова:English
Опубліковано: 2011
Предмети: